Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent target vessel revascularization when compared with bare-metal stents. However, drug-eluting stents may ...

The company is one of the leading players in the interventional cardiology market with its coronary stent product offerings. Boston Scientific markets a broad portfolio of internally-developed and ...

The following is a summary of “Evaluation of Small Vessel Bifurcation Stenting Using the Double-Kissing Culotte and Culotte ...

We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty. We conducted a nationwide analysis from ...

Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...

We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty.

The rise in cardiovascular disease prevalence, aging populations, and technological advancements in the field drive increased demand for interventional cardiology devices. As the industry prepares for ...

SMT (Sahajanand Medical Technologies), a global leader in innovative vascular solutions, announces the launch of its Hydra Transcatheter Aortic Valve Implantation (TAVI) system in Hungary, debuting ...

PORTLAND, GA, UNITED STATES, November 20, 2024 /EINPresswire / -- The global angioplasty balloons market size was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, ...